Jupiter Life Line Hospitals Limited has informed the Exchange regarding Appointment of M/s Varma & Varma, Chartered Accountants as Internal Auditor of the Company of the company w.e.f. May 15, 2026.
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jupiter Life Line Hospitals reported audited FY26 consolidated revenue of Rs 14,998 million, up 15% from Rs 13,024 million in FY25. Net profit grew marginally to Rs 1,942 million from Rs 1,938 million, with PAT essentially flat. EBITDA margins compressed due to higher professional fees (Rs 916 million) and increased finance costs (Rs 327 million). The board declared a 10% interim dividend (Rs 1 per share) with record date May 22, 2026. A stock split was approved converting 1 share of Rs 10 face value into 5 shares of Rs 2 each. Joint statutory auditors KKC & Associates and Aswin P. Malde & Co issued unmodified opinions. An exceptional item of Rs 48.87 million was recorded for incremental gratuity liability due to new labour codes. New internal auditor Varma & Varma and cost auditor M.J. Talati & Co were appointed for FY27.
The flat PAT growth despite 15% revenue increase and margin compression signals cost pressures that may concern investors. The stock split may improve retail liquidity. The clean audit opinion and dividend declaration are positives.